-
Posted by
Two Blokes 11 hours ago -
Filed in
Stock
-
3 views
British consumer healthcare group Haleon on Wednesday reported a 2.3% fall in its first-quarter revenue as sluggish demand for its cold and cough medicines outside of North America continued to weigh.
